|
||||||||||||||
By Nora Volkow, M.D., Director, National Institute on Drug Abuse
More than three decades of research supported by the National Institute on Drug Abuse (NIDA) has proven that addiction is a complex brain disease characterized by compulsive, at times uncontrollable, drug craving, seeking, and use that persist despite potentially devastating consequences. Addiction is also a developmental disease; that is, it usually starts in adolescence or even childhood and can last a lifetime if untreated. Disagreements about the nature of addiction remain: namely, whether it reflects voluntary or involuntary behavior and whether it should be punished or treated as a health issue. Even though the first time a person takes a drug, it is often by choice––to achieve a pleasurable sensation or desired emotional state––we now know from a large body of research that this ability to choose can be relatively short-lived. And when addiction takes hold in the brain, it disrupts a person’s ability to exert control over behavior—reflecting the compulsive nature of this disease.
The human brain is an extraordinarily complex and fine-tuned communications network made up of billions of cells that govern our thoughts, emotions, perceptions, and drives. Our brains reward certain behaviors such as eating or procreating––registering these as pleasurable activities so that we will repeat them. Drug addiction taps into these vital mechanisms geared for our survival. And although not a life necessity, to an addict, drugs become life itself, driving the compulsive use of drugs––even in the face of dire life consequences––that is the essence of addiction.
The rewarding effects of drugs of abuse come from large and rapid upsurges in dopamine, a neurochemical critical to stimulating feelings of pleasure and to motivating behavior. The rapid dopamine “rush” from drugs of abuse mimics but greatly exceeds in intensity and duration the feelings that occur in response to such pleasurable stimuli as the sight or smell of food, for example. Repeated exposure to large, drug-induced dopamine surges has the insidious consequence of ultimately blunting the response of the dopamine system to everyday stimuli. Thus the drug disturbs a person’s normal hierarchy of needs and desires and substitutes new priorities concerned with procuring and using the drug.
Drug abuse also disrupts the brain circuits involved in memory and control over behavior. Memories of the drug experience can trigger craving in people exposed to stressful situations or to people, places, or things they associate with their former drug use, and control over behavior becomes compromised because the affected frontal brain regions are what a person needs to exert inhibitory control over desires and emotions.
That is why addiction is a brain disease. As a person’s reward circuitry becomes increasingly dulled and desensitized by drugs, nothing else can compete with them—food, family, and friends lose their relative value, while the ability to curb the need to seek and use drugs evaporates. Ironically and cruelly, eventually even the drug loses its ability to reward, but the compromised brain leads addicted people to pursue it, anyway; the memory of the drug has become more powerful than the drug itself.
Like many other diseases, vulnerability to addiction is influenced by multiple factors, with genetic, environmental, and developmental factors all contributing. Genetics accounts for approximately half of an individual’s vulnerability to addiction, including the effects of the environment on gene function and expression. Elements of our social environments––culture, neighborhoods, schools, families, peer groups––can also greatly influence individual choices and decisions about behaviors related to substance abuse, which can in turn affect vulnerability. Indeed, addiction is a quintessential gene-by-environment-interaction disease: a person must be exposed to drugs (environment) to become addicted, yet exposure alone does not determine whether that will happen—predisposing genes interact with this and other environmental factors to create vulnerability. In fact, environmental variables such as stress or drug exposure can cause lasting changes to genes and their function, known as epigenetic changes, which can result in long-term changes to brain circuits. Genes may also mitigate the effects of environment—which is why, for example, two substance-abusing individuals growing up in the same high-risk environment may have very different outcomes.
Adding to the complexity, the contributions of environmental and genetic risk factors may also vary during the different life stages of childhood, adolescence, and young adulthood. Adolescence is the period when addiction typically takes hold. Additionally, because their brains are still undergoing rapid development in areas that contribute to decision-making, judgment, and risk-taking, adolescents tend toward immediate gratification over long-term goals. This can lead to risk-taking, including experimenting with drugs. When coupled with their increased sensitivity to social or peer influences and decreased sensitivity to negative consequences of behavior, it is easy to see why adolescents are particularly vulnerable to drug abuse.